KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Mar 20, 2026 >>  ABB India 6297.4  [ 1.63% ]  ACC 1381.9  [ 2.22% ]  Ambuja Cements 420.7  [ 0.11% ]  Asian Paints 2195.25  [ 0.40% ]  Axis Bank 1204.25  [ -0.20% ]  Bajaj Auto 9054.2  [ 2.11% ]  Bank of Baroda 280.1  [ 2.71% ]  Bharti Airtel 1846.5  [ 0.95% ]  Bharat Heavy 261.9  [ 4.07% ]  Bharat Petroleum 287.85  [ 0.65% ]  Britannia Industries 5615.85  [ -1.12% ]  Cipla 1255.85  [ 1.39% ]  Coal India 467.7  [ 2.95% ]  Colgate Palm 1896.15  [ 0.35% ]  Dabur India 431.5  [ 0.31% ]  DLF 540.7  [ -0.32% ]  Dr. Reddy's Lab. 1298.95  [ 1.95% ]  GAIL (India) 143  [ -0.90% ]  Grasim Industries 2615.3  [ 0.32% ]  HCL Technologies 1334.05  [ 1.73% ]  HDFC Bank 780.45  [ -2.41% ]  Hero MotoCorp 5277.45  [ 1.87% ]  Hindustan Unilever 2083.9  [ 0.31% ]  Hindalco Industries 874  [ -2.57% ]  ICICI Bank 1245.55  [ -0.42% ]  Indian Hotels Co. 615.75  [ 0.40% ]  IndusInd Bank 819.95  [ 0.45% ]  Infosys 1254.6  [ 2.78% ]  ITC 299.9  [ 0.62% ]  Jindal Steel 1187.3  [ 4.33% ]  Kotak Mahindra Bank 366.95  [ -0.27% ]  L&T 3434.8  [ -0.01% ]  Lupin 2322.45  [ 3.04% ]  Mahi. & Mahi 3065.3  [ 0.65% ]  Maruti Suzuki India 12602.65  [ 0.09% ]  MTNL 24.95  [ 1.51% ]  Nestle India 1193.9  [ 0.48% ]  NIIT 59.95  [ -3.94% ]  NMDC 79.85  [ 2.52% ]  NTPC 380.8  [ 1.83% ]  ONGC 265.35  [ -1.39% ]  Punj. NationlBak 111.55  [ 1.92% ]  Power Grid Corpn. 297.5  [ 0.30% ]  Reliance Industries 1414.55  [ 2.11% ]  SBI 1058.4  [ 0.90% ]  Vedanta 672.6  [ 1.12% ]  Shipping Corpn. 233.35  [ 1.48% ]  Sun Pharmaceutical 1777.45  [ 1.90% ]  Tata Chemicals 633.85  [ -0.57% ]  Tata Consumer 1050.7  [ 0.67% ]  Tata Motors Passenge 314.15  [ 1.60% ]  Tata Steel 196.7  [ 3.23% ]  Tata Power Co. 402.75  [ 1.07% ]  Tata Consult. Serv. 2390.6  [ 1.44% ]  Tech Mahindra 1384.9  [ 3.37% ]  UltraTech Cement 10927.75  [ 1.08% ]  United Spirits 1300.65  [ 0.69% ]  Wipro 191.05  [ 1.33% ]  Zee Entertainment 72.84  [ -1.51% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

20 March 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 204.24 Face Value 10.00
Bookclosure 19/09/2025 52Week High 544 EPS 5.24 P/E 48.40
Market Cap. 344.00 Cr. 52Week Low 251 P/BV / Div Yield (%) 1.24 / 0.39 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.